摘要
晚期癌症患者肿瘤骨转移诱发的骨痛是癌痛的最常见症状。癌性骨痛可显著影响患者的生存质量并使预后恶化。癌性骨痛包括背景痛及爆发性疼痛等多种形式,其发病机制复杂,包括炎性疼痛及神经病理性疼痛等,并随肿瘤的进展而变化。目前临床治疗主要包括外周及中枢镇痛药物、破骨细胞抑制剂等药物治疗,及放疗、神经损毁及神经调节等非药物治疗。阐明癌性骨痛的分子机制对优化治疗具有指导意义,本文将对转移性癌性骨痛的发病机制及临床治疗的进展进行综述。
Metastatic cancer-induced bone pain is the most common pain complaint in patients with advanced cancer.Cancer-induced bone pain can significantly affect patients'quality of life and worsen their prognosis.This bone pain includes different types,such as background pain and breakthrough pain,and its underlying molecular mechanism is complex,including inflammatory pain and neuropathic pain,which may change with tumor progression.Current clinical treatments mainly comprise drug therapies,such as peripheral and central analgesics and osteoclast blocking,and non-drug therapies,such as radiotherapy,nerve damage,and neuromodulation.Thus,elucidating the molecular mechanism underlying bone cancer-induced pain is crucial for its optimal treatment.This study aims to review advances in the current understanding of the molecular mechanism and clinical treatment of metastatic cancer-induced bone pain.
作者
王凯元
孙姗
张霄蓓(综述)
赵洪伟(审校)
Kaiyuan Wang;Shan Sun;Xiaobei Zhang;Hongwei Zhao(Department of Anesthesiology,Tianjin Medical University Cancer Institute and Hospital,National Clinical Research Center for Cancer,Tianjin Key Laboratory of Cancer Prevention and Therapy,Tianjin's Clinical Research Center for Cancer,Tianjin 300060,China)
出处
《中国肿瘤临床》
CAS
CSCD
北大核心
2020年第8期418-422,共5页
Chinese Journal of Clinical Oncology
关键词
肿瘤
骨转移
疼痛
破骨细胞
神经调控
cancer
bone metastasis
pain
osteoclast
neuromodulation
